SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001079974-19-000337
Filing Date
2019-06-20
Accepted
2019-06-20 15:08:15
Documents
76
Period of Report
2019-04-30

Document Format Files

Seq Description Document Type Size
1 apthotheca10qa1_4302019.htm 10-Q/A 373125
2 ex311.htm EX-31 10591
3 ex321.htm EX-32 6600
  Complete submission text file 0001079974-19-000337.txt   2633061

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE pcfp-20190430.xml EX-101.INS 422914
5 XBRL CALCULATION FILE pcfp-20190430_cal.xml EX-101.CAL 51673
6 XBRL DEFINITION FILE pcfp-20190430_def.xml EX-101.DEF 100138
7 XBRL LABEL FILE pcfp-20190430_lab.xml EX-101.LAB 219536
8 XBRL PRESENTATION FILE pcfp-20190430_pre.xml EX-101.PRE 198875
9 XBRL SCHEMA FILE pcfp-20190430.xsd EX-101.SCH 48806
Mailing Address 10901 ROOSEVELT BLVD., SUITE 1000C SAINT PETERSBURG FL 33716
Business Address 10901 ROOSEVELT BLVD., SUITE 1000C SAINT PETERSBURG FL 33716 727-228-3994
Apotheca Biosciences, Inc. (Filer) CIK: 0001632053 (see all company filings)

IRS No.: 472055848 | State of Incorp.: NV | Fiscal Year End: 0131
Type: 10-Q/A | Act: 34 | File No.: 000-55467 | Film No.: 19908378
SIC: 1000 Metal Mining
Office of Energy & Transportation